PROK2 and neoplasm: Thus, our findings highlight the emerging complexity of the immune-associated angiogenic drivers in the tumor microenvironment, adding new elements to the already established TAN-derived proangiogenic factors including MMP-9, VEGF, FGF-2, and Bv8/S100 proteins (summarized in a recent review) (55).